Spontaneous intramural small bowel hematoma in a patient with acute myeloid leukaemia receiving chemotherapy and nilotinib

BMJ Case Rep. 2017 Sep 27:2017:bcr2017220439. doi: 10.1136/bcr-2017-220439.

Abstract

Spontaneous intramural small bowel hematoma (SISBH) is a rare, acute abdominal condition, with increasing incidence in recent years. Excessive anticoagulation with vitamin K antagonists is the most common aetiology. We report the case of a large acute jejunal intramural hematoma in a patient with newly diagnosed acute myeloid leukaemia receiving chemotherapy and nilotinib. The patient presented with abdominal pain, haematochezia, acute anaemia and thrombocytopenia. CT of the abdomen and pelvis revealed SISBH. The patient was managed conservatively with supportive management and cessation of nilotinib therapy. The patient's symptoms improved, with subsequent CT imaging confirming resolution. This case highlights an uncommon cause of gastrointestinal bleed usually diagnosed only after radiological imaging. A correct diagnosis is important as SISBH usually responds to conservative measures, and may obviate the patient from unnecessary invasive investigations.

Keywords: chemotherapy; gi bleeding; haematology (incl blood transfusion); unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / etiology
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Diagnosis, Differential
  • Female
  • Gastrointestinal Hemorrhage / chemically induced
  • Gastrointestinal Hemorrhage / diagnosis*
  • Gastrointestinal Hemorrhage / diagnostic imaging
  • Hematoma / chemically induced
  • Hematoma / diagnosis*
  • Hematoma / diagnostic imaging
  • Humans
  • Jejunal Diseases / chemically induced
  • Jejunal Diseases / diagnosis*
  • Jejunal Diseases / diagnostic imaging
  • Leukemia, Myeloid, Acute / drug therapy*
  • Pyrimidines / adverse effects*
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Pyrimidines
  • nilotinib